254 related articles for article (PubMed ID: 16153752)
1. European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
Lehner T; Hoelscher M; Clerici M; Gotch F; Pedneault L; Tartaglia J; Gray C; Mestecky J; Sattentau Q; van de Wijgert J; Toure C; Osmanov S; Schmidt RE; Debre P; Romaris M; Hoeveler A; Di Fabio S
Vaccine; 2005 Dec; 23(48-49):5551-6. PubMed ID: 16153752
[TBL] [Abstract][Full Text] [Related]
2. The European and developing countries clinical trails partnership.
Olliaro P; Smith PG
J HIV Ther; 2004 Sep; 9(3):53-6. PubMed ID: 15534561
[TBL] [Abstract][Full Text] [Related]
3. [The WHO statement on strategies of HIV vaccinations: field trials in developing countries should await studies of the effects].
Lennholm B
Lakartidningen; 1993 Mar; 90(13):1245-6. PubMed ID: 8469070
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experimentation with HIV vaccines: scientific and ethical dilemmas].
Lallemant M; Le Coeur S
Hist Philos Life Sci; 1995; 17(1):151-69. PubMed ID: 8552748
[TBL] [Abstract][Full Text] [Related]
5. An HIV vaccine: how and when?
Esparza J
Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
[TBL] [Abstract][Full Text] [Related]
6. Designing HIV vaccines for developing countries.
Abrams S
Harv AIDS Rev; 1995; ():17-9. PubMed ID: 12319991
[TBL] [Abstract][Full Text] [Related]
7. The ethical involvement of women in HIV vaccine trials in Africa: discussion paper developed for the African AIDS Vaccine Programme.
Wassenaar DR; Barsdorf NW
Women Health; 2007; 45(1):37-50. PubMed ID: 17613461
[TBL] [Abstract][Full Text] [Related]
8. [AIDS vaccines: promises and reality].
Goudsmit J
Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
[TBL] [Abstract][Full Text] [Related]
9. Oral AIDS vaccine to be tested in the Republic of Uganda.
Gottlieb S
Bull World Health Organ; 2000; 78(7):945-6. PubMed ID: 10994272
[TBL] [Abstract][Full Text] [Related]
10. European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership.
Matee MI; Manyando C; Ndumbe PM; Corrah T; Jaoko WG; Kitua AY; Ambene HP; Ndounga M; Zijenah L; Ofori-Adjei D; Agwale S; Shongwe S; Nyirenda T; Makanga M
BMC Public Health; 2009 Jul; 9():249. PubMed ID: 19619283
[TBL] [Abstract][Full Text] [Related]
11. [AIDS vaccine: who should be selected for the test?].
Marcus U
Fortschr Med; 1995 Nov; 113(32):16-7. PubMed ID: 8543269
[No Abstract] [Full Text] [Related]
12. HIV vaccines. Agreements set vaccine on fast track to developing countries.
AIDS Wkly; 2000 Jun; ():14-5. PubMed ID: 12322533
[TBL] [Abstract][Full Text] [Related]
13. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
14. China and Thailand to start trials of AIDS vaccines.
Lenihan F
BMJ; 1993 Jun; 306(6892):1564-5. PubMed ID: 8329913
[TBL] [Abstract][Full Text] [Related]
15. Uganda will provide HIV vaccine subjects in return for services. Conference coverage (NCVDG).
Denoon DJ
AIDS Wkly Plus; 1996 Mar; ():10-1. PubMed ID: 12346962
[TBL] [Abstract][Full Text] [Related]
16. First vaccine designed for Africa cleared for testing in humans.
AIDS Wkly; 2000 Jul; ():2-4. PubMed ID: 12296005
[TBL] [Abstract][Full Text] [Related]
17. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
[TBL] [Abstract][Full Text] [Related]
18. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.
Ferrantelli F; Buttò S; Cafaro A; Wahren B; Ensoli B
Springer Semin Immunopathol; 2006 Nov; 28(3):289-301. PubMed ID: 16983452
[TBL] [Abstract][Full Text] [Related]
19. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
Esparza J; Bhamarapravati N
Lancet; 2000 Jun; 355(9220):2061-6. PubMed ID: 10885368
[TBL] [Abstract][Full Text] [Related]
20. Trial objectives and end points for measuring the efficacy of HIV vaccines.
Hoff R; Barker LF
Infect Agents Dis; 1995 Jun; 4(2):95-101. PubMed ID: 7613732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
